APA Alıntı

Pi, J., Jiang, J., Cai, H., Yang, F., Jin, H., Yang, P., . . . Chen, Z. W. (2017). GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways. Drug Deliv.

Chicago Stili Alıntı

Pi, Jiang, Jinhuan Jiang, Huaihong Cai, Fen Yang, Hua Jin, Peihui Yang, Jiye Cai, ve Zheng W. Chen. "GE11 Peptide Conjugated Selenium Nanoparticles for EGFR Targeted Oridonin Delivery to Achieve Enhanced Anticancer Efficacy By Inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK Pathways." Drug Deliv 2017.

MLA Alıntı

Pi, Jiang, et al. "GE11 Peptide Conjugated Selenium Nanoparticles for EGFR Targeted Oridonin Delivery to Achieve Enhanced Anticancer Efficacy By Inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK Pathways." Drug Deliv 2017.